Answers are grounded in this paper and cite their sources.
Acinetobacter baumannii is the most commonly associated human pathogen with infections in the genus. This opportunistic pathogen causes quite serious infections, especially in fond patients, and has the ability to quickly develop resistance to new antibiotics. In the recent past, carbapenems, a. It was the first option in the treatment of Baumannii infections. But recently there have been many clinics Acinetobacter the baumannii isolate has acquired resistance to all conventional antibiotics, including carbapenems. This compilation is Acinetobacter it can refresh our knowledge about the resistance mechanisms of baumannii; however, his revolution will continue in the future.
No takes yet. Share an insight, caveat, or question.
Khalilov et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: